114 related articles for article (PubMed ID: 16935938)
1. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis.
Berbée JF; van der Hoogt CC; Kleemann R; Schippers EF; Kitchens RL; van Dissel JT; Bakker-Woudenberg IA; Havekes LM; Rensen PC
FASEB J; 2006 Oct; 20(12):2162-4. PubMed ID: 16935938
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
[TBL] [Abstract][Full Text] [Related]
3. Apolipoproteins modulate the inflammatory response to lipopolysaccharide.
Berbée JF; Havekes LM; Rensen PC
J Endotoxin Res; 2005; 11(2):97-103. PubMed ID: 15949136
[TBL] [Abstract][Full Text] [Related]
4. Monocytic thrombomodulin triggers LPS- and gram-negative bacteria-induced inflammatory response.
Ma CY; Shi GY; Shi CS; Kao YC; Lin SW; Wu HL
J Immunol; 2012 Jun; 188(12):6328-37. PubMed ID: 22573811
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.
Berbée JF; Coomans CP; Westerterp M; Romijn JA; Havekes LM; Rensen PC
J Lipid Res; 2010 Jul; 51(7):1943-52. PubMed ID: 20335569
[TBL] [Abstract][Full Text] [Related]
6. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo.
de Haan W; Out R; Berbée JF; van der Hoogt CC; van Dijk KW; van Berkel TJ; Romijn JA; Jukema JW; Havekes LM; Rensen PC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1294-8. PubMed ID: 18992221
[TBL] [Abstract][Full Text] [Related]
8. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the development of neutralizing therapies for sepsis].
Florencia Henning M; Garda H; Bakás L
Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
[TBL] [Abstract][Full Text] [Related]
10. Functionalized dendrimers as endotoxin sponges.
Cromer JR; Wood SJ; Miller KA; Nguyen T; David SA
Bioorg Med Chem Lett; 2005 Mar; 15(5):1295-8. PubMed ID: 15713373
[TBL] [Abstract][Full Text] [Related]
11. Development of an anti-endotoxin vaccine for sepsis.
Cross AS
Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272
[TBL] [Abstract][Full Text] [Related]
12. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure.
Levels JH; Lemaire LC; van den Ende AE; van Deventer SJ; van Lanschot JJ
Crit Care Med; 2003 Jun; 31(6):1647-53. PubMed ID: 12794399
[TBL] [Abstract][Full Text] [Related]
13. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
[TBL] [Abstract][Full Text] [Related]
14. The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo.
Motzkus D; Schulz-Maronde S; Heitland A; Schulz A; Forssmann WG; Jübner M; Maronde E
FASEB J; 2006 Aug; 20(10):1701-2. PubMed ID: 16790530
[TBL] [Abstract][Full Text] [Related]
15. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitory peptide of Toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice.
Tsung A; McCoy SL; Klune JR; Geller DA; Billiar TR; Hefeneider SH
Shock; 2007 Apr; 27(4):364-9. PubMed ID: 17414417
[TBL] [Abstract][Full Text] [Related]
17. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
Morrison DC; Bucklin SE
Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
[TBL] [Abstract][Full Text] [Related]
18. Cepharanthine exerts anti-inflammatory effects via NF-κB inhibition in a LPS-induced rat model of systemic inflammation.
Kudo K; Hagiwara S; Hasegawa A; Kusaka J; Koga H; Noguchi T
J Surg Res; 2011 Nov; 171(1):199-204. PubMed ID: 20334881
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.
Netea MG; Demacker PN; Kullberg BJ; Boerman OC; Verschueren I; Stalenhoef AF; van der Meer JW
J Clin Invest; 1996 Mar; 97(6):1366-72. PubMed ID: 8617867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
